aluates Reports

$ 0.0

Automative

Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-6W6249

Global Rx Irritable Bowel Syndrome IBS Drugs Market Insights Forecast to 2028

BUY CHAPTERS

Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Research Report 2025

Code: QYRE-Auto-6W6249

Report

July 2025

Pages:67

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Ironwood Pharmaceuticals

Bausch Health

Takeda

Sebela Pharmaceuticals

Allergan plc

Rx Irritable Bowel Syndrome (IBS) Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Rx Irritable Bowel Syndrome (IBS) Drugs Market

The global market for Rx Irritable Bowel Syndrome (IBS) Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Rx Irritable Bowel Syndrome (IBS) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rx Irritable Bowel Syndrome (IBS) Drugs.

The Rx Irritable Bowel Syndrome (IBS) Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rx Irritable Bowel Syndrome (IBS) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rx Irritable Bowel Syndrome (IBS) Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Rx Irritable Bowel Syndrome (IBS) Drugs Market Report

Report Metric	Details
Report Name	Rx Irritable Bowel Syndrome (IBS) Drugs Market
CAGR	5%
Segment by Type	IBS-D Drugs IBS-C Drugs Others
Segment by Application	Women Men
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ironwood Pharmaceuticals, Bausch Health, Takeda, Sebela Pharmaceuticals, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rx Irritable Bowel Syndrome (IBS) Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rx Irritable Bowel Syndrome (IBS) Drugs Market report?

Ans: The main players in the Rx Irritable Bowel Syndrome (IBS) Drugs Market are Ironwood Pharmaceuticals, Bausch Health, Takeda, Sebela Pharmaceuticals, Allergan

What are the Application segmentation covered in the Rx Irritable Bowel Syndrome (IBS) Drugs Market report?

Ans: The Applications covered in the Rx Irritable Bowel Syndrome (IBS) Drugs Market report are Women, Men

What are the Type segmentation covered in the Rx Irritable Bowel Syndrome (IBS) Drugs Market report?

Ans: The Types covered in the Rx Irritable Bowel Syndrome (IBS) Drugs Market report are IBS-D Drugs, IBS-C Drugs, Others

Recommended Reports

Digestive Disorders Drugs

GI & Autoimmune Drugs

Pain & CNS Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 IBS-D Drugs

1.2.3 IBS-C Drugs

1.2.4 Others

1.3 Market by Application

1.3.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Women

1.3.3 Men

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Perspective (2020-2031)

2.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Growth Trends by Region

2.2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Region (2020-2025)

2.2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Region (2026-2031)

2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Market Dynamics

2.3.1 Rx Irritable Bowel Syndrome (IBS) Drugs Industry Trends

2.3.2 Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers

2.3.3 Rx Irritable Bowel Syndrome (IBS) Drugs Market Challenges

2.3.4 Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Revenue

3.1.1 Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Revenue (2020-2025)

3.1.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue

3.4 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio

3.4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2024

3.5 Global Key Players of Rx Irritable Bowel Syndrome (IBS) Drugs Head office and Area Served

3.6 Global Key Players of Rx Irritable Bowel Syndrome (IBS) Drugs, Product and Application

3.7 Global Key Players of Rx Irritable Bowel Syndrome (IBS) Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Rx Irritable Bowel Syndrome (IBS) Drugs Breakdown Data by Type

4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Type (2020-2025)

4.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Type (2026-2031)

5 Rx Irritable Bowel Syndrome (IBS) Drugs Breakdown Data by Application

5.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Application (2020-2025)

5.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2020-2031)

6.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2020-2025)

6.4 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2020-2031)

7.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2020-2025)

7.4 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2020-2031)

8.2 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2020-2031)

9.2 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2020-2025)

9.4 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2020-2031)

10.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Ironwood Pharmaceuticals

11.1.1 Ironwood Pharmaceuticals Company Details

11.1.2 Ironwood Pharmaceuticals Business Overview

11.1.3 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Introduction

11.1.4 Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2020-2025)

11.1.5 Ironwood Pharmaceuticals Recent Development

11.2 Bausch Health

11.2.1 Bausch Health Company Details

11.2.2 Bausch Health Business Overview

11.2.3 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Introduction

11.2.4 Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2020-2025)

11.2.5 Bausch Health Recent Development

11.3 Takeda

11.3.1 Takeda Company Details

11.3.2 Takeda Business Overview

11.3.3 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Introduction

11.3.4 Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2020-2025)

11.3.5 Takeda Recent Development

11.4 Sebela Pharmaceuticals

11.4.1 Sebela Pharmaceuticals Company Details

11.4.2 Sebela Pharmaceuticals Business Overview

11.4.3 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Introduction

11.4.4 Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2020-2025)

11.4.5 Sebela Pharmaceuticals Recent Development

11.5 Allergan

11.5.1 Allergan Company Details

11.5.2 Allergan Business Overview

11.5.3 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Introduction

11.5.4 Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2020-2025)

11.5.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Ironwood Pharmaceuticals

Bausch Health

Takeda

Sebela Pharmaceuticals

Allergan plc

List of Tables

Table 1. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of IBS-D Drugs

Table 3. Key Players of IBS-C Drugs

Table 4. Key Players of Others

Table 5. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2020-2025)

Table 9. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2026-2031)

Table 11. Rx Irritable Bowel Syndrome (IBS) Drugs Market Trends

Table 12. Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers

Table 13. Rx Irritable Bowel Syndrome (IBS) Drugs Market Challenges

Table 14. Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints

Table 15. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Players (2020-2025)

Table 17. Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2024)

Table 18. Ranking of Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Rx Irritable Bowel Syndrome (IBS) Drugs, Headquarters and Area Served

Table 21. Global Key Players of Rx Irritable Bowel Syndrome (IBS) Drugs, Product and Application

Table 22. Global Key Players of Rx Irritable Bowel Syndrome (IBS) Drugs, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2020-2025)

Table 26. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2026-2031)

Table 28. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2020-2025)

Table 30. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2026-2031)

Table 32. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 47. Ironwood Pharmaceuticals Company Details

Table 48. Ironwood Pharmaceuticals Business Overview

Table 49. Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product

Table 50. Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2020-2025) & (US$ Million)

Table 51. Ironwood Pharmaceuticals Recent Development

Table 52. Bausch Health Company Details

Table 53. Bausch Health Business Overview

Table 54. Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Product

Table 55. Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2020-2025) & (US$ Million)

Table 56. Bausch Health Recent Development

Table 57. Takeda Company Details

Table 58. Takeda Business Overview

Table 59. Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Product

Table 60. Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2020-2025) & (US$ Million)

Table 61. Takeda Recent Development

Table 62. Sebela Pharmaceuticals Company Details

Table 63. Sebela Pharmaceuticals Business Overview

Table 64. Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product

Table 65. Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2020-2025) & (US$ Million)

Table 66. Sebela Pharmaceuticals Recent Development

Table 67. Allergan Company Details

Table 68. Allergan Business Overview

Table 69. Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Product

Table 70. Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2020-2025) & (US$ Million)

Table 71. Allergan Recent Development

Table 72. Research Programs/Design for This Report

Table 73. Key Data Information from Secondary Sources

Table 74. Key Data Information from Primary Sources

Table 75. Authors List of This Report

List of Figures

Figure 1. Rx Irritable Bowel Syndrome (IBS) Drugs Picture

Figure 2. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type: 2024 VS 2031

Figure 4. IBS-D Drugs Features

Figure 5. IBS-C Drugs Features

Figure 6. Others Features

Figure 7. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application: 2024 VS 2031

Figure 9. Women Case Studies

Figure 10. Men Case Studies

Figure 11. Rx Irritable Bowel Syndrome (IBS) Drugs Report Years Considered

Figure 12. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region: 2024 VS 2031

Figure 15. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Players in 2024

Figure 16. Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2024

Figure 18. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2020-2031)

Figure 20. United States Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2020-2031)

Figure 24. Germany Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2020-2031)

Figure 32. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2020-2031)

Figure 40. Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2020-2031)

Figure 44. Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Ironwood Pharmaceuticals Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2020-2025)

Figure 48. Bausch Health Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2020-2025)

Figure 49. Takeda Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2020-2025)

Figure 50. Sebela Pharmaceuticals Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2020-2025)

Figure 51. Allergan Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2020-2025)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Irritable Bowel Syndrome Drug Market Research Report 2024

Irritable Bowel Syndrome Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Irritable Bowel Syndrome IBS Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Irritable Bowel Syndrome Medication Market Research Report 2025

Irritable Bowel Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Digestive Drugs Market Insights Forecast to 2030

Global Gastrointestinal Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Short Bowel Syndrome SBS Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global IBS Probiotic Supplement Market Research Report 2024

Global Gastrointestinal Therapeutics Market Research Report 2024

Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Idiopathic Constipation Drugs Market Research Report 2024

Global Digestive System Drugs Market Research Report 2024

Global IBS C Drugs Market Research Report 2024

Global Irritable Bowel Syndrome with Diarrhea IBS D Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global IBS Implant Market Research Report 2024

Short Bowel Syndrome Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for Short Bowel Syndrome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastrointestinal Drugs Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions